TrialCancer immunology, immunotherapy : CII2013

Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients.

Michael A Morse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.